Tough on #Cancer not on Patients. Initiating Phase II trials on the Indenoisoquinolines, a new class of non-Camptothecins a novel anti-cancer fighting drug.

Biotechnology

Health Care

Gibson Oncology

Randall B Riggs

Clifford T Solomon

Theodore C Solomon

Elizabeth L Rogers

The Leadership Team at Gibson Oncology spearheads the company's strategic direction, oversees clinical development, and ensures operational excellence in advancing Phase II trials of Indenoisoquinolines. Comprising the company's founders and key executives, this team drives efforts to deliver innovative, patient-friendly cancer treatments.

Leadership Team

About

Team members

Other teams at Gibson Oncology

Scientific Advisory Team